BioWorld-International-2007-06-20
Diamyd Shares Fall On News Of Diabetes Trial Debacle
Diamyd Shares Fall On News Of Diabetes Trial Debacle
Diamyd Medical AB lost around 40 percent of its value Monday on news that it had to jettison a Phase II/III clinical trial of Diamyd, a therapeutic vaccine in development for treating autoimmune diabetes.(BioWorld International)

